Chemoinformaics analysis of 2-Methyl-2-vinyloxirane
| Molecular Weight | 84.118 | nRot | 1 |
| Heavy Atom Molecular Weight | 76.054 | nRig | 4 |
| Exact Molecular Weight | 84.0575 | nRing | 1 |
| Solubility: LogS | -0.555 | nHRing | 1 |
| Solubility: LogP | 1.037 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 14 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 14.4863 |
| nHD | 0 | BPOL | 9.76166 |
| QED | 0.34 |
| Synth | 4.002 |
| Natural Product Likeliness | 2.635 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.284 |
| MDCK | 0.0000356 |
| BBB | 0.971 |
| PPB | 0.496412 |
| VDSS | 1.162 |
| FU | 0.545844 |
| CYP1A2-inh | 0.14 |
| CYP1A2-sub | 0.884 |
| CYP2c19-inh | 0.073 |
| CYP2c19-sub | 0.866 |
| CYP2c9-inh | 0.015 |
| CYP2c9-sub | 0.2 |
| CYP2d6-inh | 0.018 |
| CYP2d6-sub | 0.326 |
| CYP3a4-inh | 0.088 |
| CYP3a4-sub | 0.442 |
| CL | 5.348 |
| T12 | 0.731 |
| hERG | 0.011 |
| Ames | 0.096 |
| ROA | 0.104 |
| SkinSen | 0.393 |
| Carcinogencity | 0.255 |
| EI | 0.991 |
| Respiratory | 0.134 |
| NR-Aromatase | 0.015 |
| Antiviral | No |
| Prediction | 0.950861 |